Fiche du document
- doi: 10.33963/v.kp.97315
- issn: 0022-9032
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.33963/v.kp.97315
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/37718589
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1897-4279
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_5FE1A04EE6753
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Cardiac failure Failure, Heart Insufficiency, Cardiac Cardiac insufficiency Diuretics and diuresis Water pillsCiter ce document
M. Burnier et al., « How to optimize the use of diuretics in patients with heart failure? », Serveur académique Lausannois, ID : 10.33963/v.kp.97315
Métriques
Partage / Export
Résumé
Considering the pathophysiology and clinical presentation of heart failure, using diuretics or drugs with diuretic properties is indispensable for adequate management of heart failure patients. However, in clinical practice, fluid expansion is often undiagnosed, and diuretic therapy is not always adequately titrated. Today, several drug classes with diuretic properties are available in addition to classical thiazides, thiazide-like, and loop diuretics. The purpose of this short review is to discuss different ways to optimize diuretic therapy using currently available drugs. Several approaches are considered, including a combination of diuretics to obtain a sequential nephron blockade, use of a drug combining a blocker of the renin-angiotensin system (RAS) and an inhibitor of the metabolism of natriuretic peptides (ARNI), prescription of potassium binders to maintain and up-titrate RAS blockers and mineralocorticoid antagonists, and finally use of inhibitors of renal reabsorption of glucose through the sodium-glucose cotransporter 2 system. Optimal use of these various drug classes should improve the quality of life and reduce the need for hospital admissions and mortality in heart failure patients.